Technology is driving change in life science and healthcare research and development. Pistoia Alliance Virtual Conference Week, to be held October 19-23, 2020, will offer a unique opportunity for stakeholders to come together to debate important developments across the pharma and life science R&D value chain.
Presentations, panel discussions, and virtual networking will provide stimulus and opportunity for discussions to identify key areas where the Pistoia Alliance can set up collaborative projects that will drive innovation and make a real difference to research and ultimately to patients.
Key themes that will be addressed will range from Emerging Science & Technology, Digital, Lab of the Future through Artificial Intelligence and its underlying disciplines to Real World Data along with an update on the current Pistoia Alliance project portfolio.
Sponsors
A wide-ranging number of sponsorship opportunities are available at this event. Please contact Conference and Events Lead Zahid Tharia (zahid.tharia@pistoiaalliance.org) for further information.
Hear from 30+ Life Science Industry Leaders
-
-
Jay Bradner
President, Novartis Institute for Biomedical Research
-
-
Dr. Merdad Parsey
Chief Medical Officer, Gilead Sciences
-
-
Andrew Plump
President, Research & Development, Takeda Pharmaceutical Company
-
-
Paul Sonnier
Innovation and Growth Leader, PA Consulting
-
-
Dr. Steve Arlington
President, Pistoia Alliance
-
-
Michael Benecky
Senior Director of Regulatory Affairs, UCB
-
-
Xavier Briand
Senior Principal Scientist at Novartis
-
-
William M. Burns
Former CEO, Roche Pharmaceuticals & Member of the Pistoia Alliance Advisory Board
-
-
Hugo Ceulemans
Scientific Director Discovery Data Sciences, Janssen
-
-
Hans Constandt
President & Founder, ONTOFORCE
-
-
Hideyoshi Fuji
Manager, Astellas Pharma
-
-
Paul Denny-Gouldson
Consultant, Pistoia Alliance
-
-
Thibault Géoui
Senior Director Discovery Biology & Predictive Risk Management, RELX, Elsevier
-
-
Amy Gordon Franzen
Vice President of Operations, Tempus Labs
-
-
Alexandra Grebe de Barron
Data Product Owner in Digital Transformation & IT – Global Data Assets
-
-
Tina Flatau
Chair, Action Duchenne
-
-
Manuel Guzman
President, CAS
-
-
Kevin Hayes
Global Lead, Data Science and Informatics Strategy and Communication, Corteva Agriscience
-
-
Jens Hoefkens
Industry Principal Director, Accenture, INTIENT Research
-
-
Thomas Hudson
SVP, R&D and Chief Scientific Officer, AbbVie
-
-
Sven Jungmann
Chief Medical Officer, FoundersLane
-
-
David King
Project Manager, Bayer
-
-
Palani Kumaresan
Life Cycle Leader, Roche Diagnostics International
-
-
Eric Lefkofsky
Founder & CEO, Tempus Labs
-
-
Camille Marini
CTO, Owkin
-
-
Rhea Mehta
Co-Founder, Bowhead Health
-
-
Trey Miller
Product Manager, Benchling
-
-
Chris Moore
President, Veeva Europe
-
-
Steve Penn
Medicinal Sciences Information Strategy Lead, Pfizer
-
-
Vasu Rangadass
President & CEO, L7 Informatics
-
-
Bryn Roberts
SVP, Global Head of Operations for Pharma Research & Early Development, Roche
-
-
Rob Scott
Chief Medical Officer, AbbVie (Retired)
-
-
Yugal Sharma
Senior Director, Solutions, CAS
-
-
Jonathan Sheldon
SVP, QIAGEN Digital Insights
-
-
Shweta Singh Maniar
Life Sciences Leader, Healthcare & Life Sciences, Google Cloud
-
-
Penny Smee
Tech Director & Senior Product Owner, GSK
-
-
Silvina Catuara Solarz
Strategy Manager, Alpha Health
-
-
Laura Williams
Discovery Biology Technology Lead, GSK